Financials
- Market Capitalization 1.76 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-4.3
주가매출액비율
162.41
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 2066 | NTLA Intellia Therapeutics, Inc. - Common Stock | 13.02 USD | -8.44% | -27.06% | +1.88% | -5.10% | 1.82 B USD | ||
| 2069 | IOVA Iovance Biotherapeutics, Inc. - Common Stock | 4.04 USD | -4.49% | -4.94% | -1.94% | +113.76% | 1.80 B USD | ||
| 2093 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.30 USD | -7.30% | -16.46% | 0.00% | -37.85% | 1.75 B USD | ||
| 2112 | FTRE Fortrea Holdings Inc. - Common Stock | 17.86 USD | +0.56% | -0.78% | +6.88% | +250.88% | 1.69 B USD |